...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Design, synthesis and biological evaluation of novel nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.
【24h】

Design, synthesis and biological evaluation of novel nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.

机译:设计,合成和生物学评估新型含氮和硫的杂1,4-萘醌类作为有效的抗真菌和抗菌剂。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of 2-Arylamino-3-chloro-1,4-naphthoquinones (3), 2-Amino-3-arylsulfanyl-1,4-naphthoquinones (5), 2-Arylamino-3-arylsulfanyl-1,4-naphthoquinones (6), Dihydrobenzo[f]naphtho[2,3-b][1,4]thiazepine-6,11-diones (9) (via Pictet-Spengler cyclization), Isoindoline-1,3-dione derivatives of 1,4-naphthoquinone (13), 2,2'-(1,4-Dioxo-1,4-dihydronaphthalene-2,3-diyl)bis(methylene)dibenzonitrile (14), 13-Amino-12-substituted-6H-benzo[e]naphtho [2,3-b][1,4]diazepine-6,11(12H)-diones (15-16), 2-Chloro-3-arylsulfanyl-1,4-naphthoquinones (17-18) and 3-Methyl-6H-benzo[b]phenothiazine-6,11(12H)-dione (19) were synthesized and studied for their antifungal and antibacterial activities. The results indicate that compounds 3b, 5a and 5b have potent antifungal activity. Amongst the most promising antifungal compounds, 3b showed better antifungal activity than clinically prevalent antifungal drug Fluconazole (MIC(50)=2.0 microg/mL) against Sporothrix schenckii (MIC(50)=1.56 microg/mL), significant profile against Candida albicans (MIC(50)=1.56 microg/mL), Cryptococcus neoformans (MIC(50)=0.78 microg/mL) and Trichophyton mentagraphytes (MIC(50)=1.56 microg/mL) and same antifungal activity when compared with Amphotericin-B against C. neoformans (MIC(50)=0.78 microg/mL). Compounds 3b, 5a and 5b also showed promising antibacterial activity.
机译:一系列2-Arylamino-3-chloro-1,4-naphthoquinones(3),2-Amino-3-arylulfanyl-1,4-naphthoquinones(5),2-Arylamino-3-arylsulfanyl-1,4-naphthoquinones (6),二氢苯并[f]萘[2,3-b] [1,4]噻氮平-6,11-二酮(9)(通过Pictet-Spengler环化),1的异吲哚啉-1,3-二酮衍生物, 4-萘醌(13),2,2'-(1,4-二氧-1,4-二氢萘-2,3-二基)双(亚甲基)二苄腈(14),13-氨基-12-取代-6H-苯并[e]萘[2,3-b] [1,4]二氮杂-6,11(12H)-二酮(15-16),2-氯-3-芳基硫烷基-1,4-萘醌(17-18 )和3-甲基-6H-苯并[b]吩噻嗪-6,11(12H)-二酮(19)的合成并研究其抗真菌和抗菌活性。结果表明化合物3b,5a和5b具有有效的抗真菌活性。在最有前途的抗真菌化合物中,3b的抗真菌活性比临床上普遍使用的抗真菌药Fluconazole(MIC(50)= 2.0 microg / mL)对Sporothrix schenckii(MIC(50)= 1.56 microg / mL)有更好的抗真菌作用,对白色念珠菌( MIC(50)= 1.56 microg / mL),新隐球菌(MIC(50)= 0.78 microg / mL)和毛癣菌(MIC(50)= 1.56 microg / mL)和与两性霉素B对抗C的抗真菌活性相同新甲虫(MIC(50)= 0.78 microg / mL)。化合物3b,5a和5b也显示出有希望的抗菌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号